CA Alchemy Investments, a shareholder in Piramal Pharma, has re-pledged 9.84 Cr (98,400,000) shares, representing 7.39% of the company.

Deutsche Bank AG, acting as a security agent, now holds a pledge over a total of 23.87 Cr (238,663,700) Piramal Pharma shares, accounting for 17.93% of the equity.

This re-pledge follows an earlier release of these shares.